148 related articles for article (PubMed ID: 36529093)
1. HyperIgE in hypomorphic recombination-activating gene defects.
Castiello MC; Brandas C; Capo V; Villa A
Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
[TBL] [Abstract][Full Text] [Related]
2. Omenn syndrome does not live by V(D)J recombination alone.
Marrella V; Maina V; Villa A
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
[TBL] [Abstract][Full Text] [Related]
3. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.
Yu X; Almeida JR; Darko S; van der Burg M; DeRavin SS; Malech H; Gennery A; Chinn I; Markert ML; Douek DC; Milner JD
J Allergy Clin Immunol; 2014 Apr; 133(4):1109-15. PubMed ID: 24406074
[TBL] [Abstract][Full Text] [Related]
4. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
5. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
6. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
Villa A; Sobacchi C; Notarangelo LD; Bozzi F; Abinun M; Abrahamsen TG; Arkwright PD; Baniyash M; Brooks EG; Conley ME; Cortes P; Duse M; Fasth A; Filipovich AM; Infante AJ; Jones A; Mazzolari E; Muller SM; Pasic S; Rechavi G; Sacco MG; Santagata S; Schroeder ML; Seger R; Strina D; Ugazio A; Väliaho J; Vihinen M; Vogler LB; Ochs H; Vezzoni P; Friedrich W; Schwarz K
Blood; 2001 Jan; 97(1):81-8. PubMed ID: 11133745
[TBL] [Abstract][Full Text] [Related]
7. Partial V(D)J recombination activity leads to Omenn syndrome.
Villa A; Santagata S; Bozzi F; Giliani S; Frattini A; Imberti L; Gatta LB; Ochs HD; Schwarz K; Notarangelo LD; Vezzoni P; Spanopoulou E
Cell; 1998 May; 93(5):885-96. PubMed ID: 9630231
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
Capo V; Castiello MC; Fontana E; Penna S; Bosticardo M; Draghici E; Poliani LP; Sergi Sergi L; Rigoni R; Cassani B; Zanussi M; Carrera P; Uva P; Dobbs K; Sacchetti N; Notarangelo LD; van Til NP; Wagemaker G; Villa A
J Allergy Clin Immunol; 2018 Sep; 142(3):928-941.e8. PubMed ID: 29241731
[TBL] [Abstract][Full Text] [Related]
9. RAG gene defects at the verge of immunodeficiency and immune dysregulation.
Villa A; Notarangelo LD
Immunol Rev; 2019 Jan; 287(1):73-90. PubMed ID: 30565244
[TBL] [Abstract][Full Text] [Related]
10. RAGs and BUGS: An alliance for autoimmunity.
Rigoni R; Grassi F; Villa A; Cassani B
Gut Microbes; 2016 Nov; 7(6):503-511. PubMed ID: 27575988
[TBL] [Abstract][Full Text] [Related]
11. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
[TBL] [Abstract][Full Text] [Related]
12. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.
Wada T; Takei K; Kudo M; Shimura S; Kasahara Y; Koizumi S; Kawa-Ha K; Ishida Y; Imashuku S; Seki H; Yachie A
Clin Exp Immunol; 2000 Jan; 119(1):148-55. PubMed ID: 10606976
[TBL] [Abstract][Full Text] [Related]
13. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.
Matangkasombut P; Pichavant M; Saez DE; Giliani S; Mazzolari E; Finocchi A; Villa A; Sobacchi C; Cortes P; Umetsu DT; Notarangelo LD
Blood; 2008 Jan; 111(1):271-4. PubMed ID: 17890453
[TBL] [Abstract][Full Text] [Related]
14. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
[TBL] [Abstract][Full Text] [Related]
15. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
16. Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency.
Walter JE; Rucci F; Patrizi L; Recher M; Regenass S; Paganini T; Keszei M; Pessach I; Lang PA; Poliani PL; Giliani S; Al-Herz W; Cowan MJ; Puck JM; Bleesing J; Niehues T; Schuetz C; Malech H; DeRavin SS; Facchetti F; Gennery AR; Andersson E; Kamani NR; Sekiguchi J; Alenezi HM; Chinen J; Dbaibo G; ElGhazali G; Fontana A; Pasic S; Detre C; Terhorst C; Alt FW; Notarangelo LD
J Exp Med; 2010 Jul; 207(7):1541-54. PubMed ID: 20547827
[TBL] [Abstract][Full Text] [Related]
17. Recombination activating gene and its defects.
Villa A; Sobacchi C; Vezzoni P
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):491-5. PubMed ID: 11964731
[TBL] [Abstract][Full Text] [Related]
18. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
Niehues T; Perez-Becker R; Schuetz C
Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
[TBL] [Abstract][Full Text] [Related]
19. Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies.
Villa A; Sobacchi C; Vezzoni P
Isr Med Assoc J; 2002 Mar; 4(3):218-21. PubMed ID: 11908269
[TBL] [Abstract][Full Text] [Related]
20. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.
Delmonte OM; Villa A; Notarangelo LD
Blood; 2020 Feb; 135(9):610-619. PubMed ID: 31942628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
